Guardant Health, Inc. (GH)

USD 43.71

(6.23%)

Net Debt Summary of Guardant Health, Inc.

  • Guardant Health, Inc.'s latest annual net debt in 2023 was 220.22 Million USD , down -82.06% from previous year.
  • Guardant Health, Inc.'s latest quarterly net debt in 2024 Q2 was 305.87 Million USD , up 40.17% from previous quarter.
  • Guardant Health, Inc. reported annual net debt of 1.22 Billion USD in 2022, up 41.32% from previous year.
  • Guardant Health, Inc. reported annual net debt of 868.67 Million USD in 2021, up 5737.85% from previous year.
  • Guardant Health, Inc. reported quarterly net debt of 305.87 Million USD for 2024 Q2, up 40.17% from previous quarter.
  • Guardant Health, Inc. reported quarterly net debt of 220.22 Million USD for 2023 Q4, down -75.56% from previous quarter.

Annual Net Debt Chart of Guardant Health, Inc. (2023 - 2016)

Historical Annual Net Debt of Guardant Health, Inc. (2023 - 2016)

Year Net Debt Net Debt Growth
2023 220.22 Million USD -82.06%
2022 1.22 Billion USD 41.32%
2021 868.67 Million USD 5737.85%
2020 14.88 Million USD 113.53%
2019 -109.97 Million USD 21.63%
2018 -140.32 Million USD -95.93%
2017 -71.62 Million USD -332.7%
2016 -16.55 Million USD 0.0%

Peer Net Debt Comparison of Guardant Health, Inc.

Name Net Debt Net Debt Difference
Aclaris Therapeutics, Inc. -39.45 Million USD 658.215%
Applied DNA Sciences, Inc. -5.91 Million USD 3823.8%
Aspira Women's Health Inc. -331 Thousand USD 66633.837%
Biodesix, Inc. 34.3 Million USD -541.93%
BioNexus Gene Lab Corp. -5.79 Million USD 3899.676%
bioAffinity Technologies, Inc. -1.24 Million USD 17818.361%
bioAffinity Technologies, Inc. -1.24 Million USD 17818.361%
Bionano Genomics, Inc. 34.88 Million USD -531.349%
CareDx, Inc -47.97 Million USD 559.036%
Check-Cap Ltd. -24.75 Million USD 989.59%
Castle Biosciences, Inc. -83.53 Million USD 363.647%
DarioHealth Corp. -7.54 Million USD 3017.687%
Exact Sciences Corporation 1.94 Billion USD 88.703%
Fulgent Genetics, Inc. -82.56 Million USD 366.728%
ICON Public Limited Company 3.56 Billion USD 93.814%
IDEXX Laboratories, Inc. 493.94 Million USD 55.415%
Illumina, Inc. 1.21 Billion USD 81.859%
Intelligent Bio Solutions Inc. -5.43 Million USD 4153.762%
iSpecimen Inc. -2.14 Million USD 10355.413%
Standard BioTools Inc. 46.5 Million USD -373.545%
MDxHealth SA 18.88 Million USD -1066.148%
23andMe Holding Co. -141.37 Million USD 255.778%
Medpace Holdings, Inc. -103.32 Million USD 313.136%
Myriad Genetics, Inc. 88.1 Million USD -149.974%
Mainz Biomed B.V. 349.85 Thousand USD -62848.078%
ENDRA Life Sciences Inc. -2.43 Million USD 9127.532%
NeoGenomics, Inc. 269.19 Million USD 18.189%
Neogen Corporation 735.62 Million USD 70.063%
Inotiv, Inc. 382.14 Million USD 42.371%
Natera, Inc. -200.1 Million USD 210.057%
OpGen, Inc. 11.89 Million USD -1751.91%
OPKO Health, Inc. 230.68 Million USD 4.533%
Psychemedics Corporation 334 Thousand USD -65836.228%
Prenetics Global Limited -43.33 Million USD 608.172%
Prenetics Global Limited -43.33 Million USD 608.172%
Precipio, Inc. -386 Thousand USD 57153.627%
Personalis, Inc. -8.02 Million USD 2845.288%
RadNet, Inc. 1.14 Billion USD 80.826%
Sera Prognostics, Inc. -2.02 Million USD 10991.543%
Sotera Health Company 2.02 Billion USD 89.127%
Neuronetics, Inc. 2.79 Million USD -7773.686%
Star Equity Holdings, Inc. -15.33 Million USD 1535.92%
Star Equity Holdings, Inc. -15.33 Million USD 1535.92%
Trinity Biotech plc 63.73 Million USD -245.53%
T2 Biosystems, Inc. 33.8 Million USD -551.386%
Twist Bioscience Corporation -192.4 Million USD 214.463%
Exagen Inc. -12.77 Million USD 1824.295%